EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, HRTX: Heron Therapeutics

09 Sep 26 15:59
LAST:

0.3376

CHANGE:
 0.02		OPEN:
0.3549		HIGH:
0.3549		ASK:
14.0500		VOLUME:
1.63M
CHG(%):
4.86		PREV:
0.3500		LOW:
0.3300		BID:
12.9800		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
09 Sep 260.34270.35070.33000.33301.79M
08 Sep 260.34800.35500.33000.35001.06M
04 Sep 260.33750.35500.32530.34391.88M
03 Sep 260.32700.33370.31060.33001.31M
02 Sep 260.31100.32800.30610.31292.17M
01 Sep 260.31800.33000.30160.31502.38M
31 Aug 260.33700.33700.31400.31802.13M
28 Aug 260.33000.33500.31750.3266953.1K
27 Aug 260.31800.34150.31080.33211.87M
26 Aug 260.32010.32900.30290.31223.1M

PROFILE

Name:Heron Therapeutics
About:Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; and APONVIE, an intravenous formulation of a substance P/neurokinin-1 receptor antagonist indicated for the prevention of postoperative nausea and vomiting in adults. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in Cary, North Carolina.
Sector:Healthcare
Industry:Biotechnology
Address:100 Regency Forest Drive, Cary, NC, United States, 27518
Website:https://www.herontx.com
CUSIP:00754G102
CIK:0000818033
ISIN:US4277461020
FIGI:BBG000G2GJT7
LEI:549300DR2I1DOPD2IX53

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:0.331.1%
MA10:0.333.1%
MA20:0.324.0%
MA50:0.4019.2%
MA100:0.6077.6%
MA200:0.88159.9%
STO9:47.74
STO14:52.17
RSI14:57.29
WPR14:-41.46
MTM14:0.02
ROC14:0.08 
ATR:0.02 
Week High:0.365.2%
Week Low:0.3110.3%
Month High:0.4225.2%
Month Low:0.30159.9%
Year High:1.58366.5%
Year Low:0.3013.5%
Volatility:70.14 

RECENT SPLITS

Date Ratio
13 Jan 20141-20
25 May 20071-4